PINK1 is a target of T cell responses in Parkinson’s disease
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder. While there is no curative treatment, the immune system’s involvement with autoimmune T cells that recognize the protein α-synuclein (α-syn) in a subset of individuals ...
Gregory P. Williams +14 more
doaj +1 more source
Leucine-rich repeat kinase 2 (LRRK2) is the most common gene responsible for familial Parkinson's disease (PD). The gene product of LRRK2 contains multiple protein domains, including armadillo repeat, ankyrin repeat, leucine-rich repeat (LRR), Ras-of ...
Toshiki Tezuka +20 more
doaj +1 more source
Presentation of ichthyosis after substrate reduction therapy in Gaucher type 1 [PDF]
We describe a case in which a type 1 Gaucher patient developed ichthyosis weeks after starting substrate reduction therapy (SRT) with eliglustat. There are no reports of ichthyosis in the literature in enzyme replacement or SRT for Gaucher disease ...
Herbster, Jack +6 more
core +1 more source
Early⁃onset Parkinson's disease caused by LRRK2 R1067Q and GBA R202Q variation: one case report
LIU Chen +3 more
doaj +1 more source
Phenotypic Spectrum of Type 2-3 Gaucher Disease: A Case Study in the Balkan Genotype. [PDF]
Cullufi P +8 more
europepmc +1 more source
Comparative analysis of the silk gland transcriptomes between the domestic and wild silkworms [PDF]
Bi-Li Hu +4 more
core +1 more source
GBA3 as a regulator of sphingolipid metabolism in the progression of hepatocellular carcinoma. [PDF]
Wang X, Li L, Sun T, Qiu Z.
europepmc +1 more source
Resolving versus non-resolving sphingolipid dynamics during macrophage activation: a time-resolved metabolic analysis. [PDF]
Chiappa NF, Lal N, Botchwey EA.
europepmc +1 more source
Editorial: Exploring gut neuroimmunology: focus on the enteric nervous system in health and disease. [PDF]
Otero-Losada M, Bhave S, Dora D.
europepmc +1 more source
Досягнення у вивченні та лікуванні хвороби паркінсона в Україні [PDF]
Грінкевич, В. М. +2 more
core

